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Abstract
Background: Hepatitis B virus (HBV) is the major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
The global epidemiological scenario of HBV infection has been changing rapidly over the last two decades due to
an effective immunization programme initiated by the World Health Organization. The objective of this study is to
estimate the prevalence of HBV in apparently healthy young people and to identify the risk factors of transmission
of the HBV among this population in Bangui.
Methods: Dried blood Spots from 801 adolescent high school and young adult university students were prepared
by spotting a drop of whole blood (4 spots) from the same fingerprick onto Whatman filter paper. A blood sample
aliquot eluted from DBS was then processed with commercial ELISA tests (Abbott Murex, Dartfort, UK) to detect
HBsAg antigen, Anti-HBc and Anti-HBs antibodies).
Results: The overall prevalence was 42.3% for antibody to hepatitis B core antigen, 15.5% for HBsAg of which 1.3%
of HBsAg alone. HBV familial antecedents, sexual activity and socioeconomic conditions were the main risk factors
of HBV infection encountered in the adolescents and young adults.
Conclusion: These results show for the first time the high prevalence of HBV in apparently healthy young people
in Bangui. This high prevalence is age- and sex-independent. Transmission risk factors were a familial antecedent of
HBV, no utilisation of condoms and public scholarship. To lower HBV prevalence, an adequate program of active
screening and vaccination for adolescents and young adults should be implemented, along with a universal
immunization program.
Background
Hepatitis B virus (HBV) infection represents a major
health problem, with 2 billion people infected worldwide
and more than 400 million chronic carriers of HBV.
Globally it causes about 1.2 million deaths per year due
to various complications including chronic hepatitis, cir-
rhosis, and liver cancer [1-4]. It is estimated that about
one third of the infected individuals have symptoms and/
or biological evidence of hepatitis. It is well established
that the earlier the contamination, the higher the risk of
chronic infection which is as high as 90% in infected
infants. Chronic carriers have a high mortality rate due
to complications. In Sub-Saharan Africa, the prevalence
of HBV surface antigen (HBsAg) is 3 - 20% and markers
of past exposure ranging from 60 - 99% [5].
The Central African Republic (CAR), located in tropi-
cal Africa, is considered an area of high endemicity for
HBV infection with most HBV strains that belong to the
West African genotype E [6]. The transmission of this
disease is believed to be main l yb ys e x u a l ,v e r t i c a la n d
intrafamilial routes [7]. Previous study on young sexually
active adults, examined in a Public health clinic for
sexually transmitted disease in CAR, has shown a high
prevalence of HBsAg (14%) with a prevalence of anti-
HBc antibodies at 89% [8]. In addition, a survey carried
out in the pediatric hospital of Bangui revealed a preva-
lence of 22.3% in children under 16 years of age with a
precocity of the infection (25% of the children were
infected before they reached one year) and a high
increase of prevalence (48%) among children aged of
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any medium, provided the original work is properly cited.10 to 15 [9]. Since these studies have been carried out in
the hospital environment they do not obligatorily reflect
the prevalence of HBV in the general population. Dur-
ing adolescence, individuals are more prone to risk
behaviors such as alcohol abuse, multiple partners and
are exposed to sexually transmitted diseases [10,11].
Hepatitis B is a preventable disease and it is necessary
to establish its importance and distribution among the
population in order to evaluate the need for implement-
ing preventive action [12,13]. Although, CAR has a high
prevalence of HBV infections, there is for the moment
neither a national program of prevention nor national
recommendations to limit the transmission of this dis-
ease. Thus, the purpose of this survey was to determine
the prevalence of HBV in an apparently healthy popula-
tion and identify the risk factors of infection among
adolescents and young adults in order to propose strate-
gies of prevention.
Methods
Study population
The study was carried out from 1
st to 28
th of February,
2007 in seven (7) public and five (5) private high
schools, randomly selected, and in the University of
Bangui. The objectives of the survey were presented to
each high school Director and to the General Secretary
of the University in order to obtain their authorization.
To evaluate the prevalence and risk factors for HBV
infection, the study sample was calculated using the
Schwartz formula on the basis of an alpha error of 5%,
an expected HBsAg prevalence of 22.3% [9] and a preci-
sion of 3%. In accordance with these data, the required
sample size was 740 individuals.
A total of 801 individuals were sampled and com-
pleted the questionnaire. In addition to the standard
questions on socio-economic status, the following risk
factors were investigated: HBV familial antecedents (at
least one of parents or siblings was a chronic HBV car-
rier), tattooing, body piercing, alcohol and illicit drug
consumption, number of sexual partners, age of first
sexual intercourse. Individuals were assured that the
obtained information would not be shared with parents
(except in the case of students under 18 years of age),
school staff and any other person. The students were
almost evenly distributed among the 8 districts of the
city and the adjacent town of Bimbo.
Ethical approval
Informed consent was obtained from all individuals. For
subjects under 18, parental consent was required. Each
participant and/or parent was informed of the results of
the serology. The study was approved by the Scientific
Committee of the Faculty of Medicine of the University
of Bangui.
Specimen Collection
Dried blood spots (DBS) were prepared by spotting a
drop of whole blood (4 spots) from one finger prick
onto Whatman filter paper. Blood collections were car-
ried out in the amphitheatres and/or the classrooms.
Once air-dried, the filter papers were sealed in plastic
bags, brought to the laboratory and stored at - 20°C in
the presence of a desiccant until testing.
Serological assays
In this study, we slightly modified the technique of DBS
that was previously described [14]. Briefly, blood samples
were extracted from DBS by punching one bloodstained
circle of 6 mm diameter from the filter paper, and then
incubated overnight in 500 μl PBS at room temperature.
After a rapid centrifugation, the supernatant was used for
testing. HBs antigen Version 3, Anti-HBc and Anti-HBs
antibodies (Abbott-Murex Biotech Ltd, Dartford, Kent,
UK) were performed according to manufacturer’s recom-
mendations on all samples. The value of the technique
was ascertained by comparing the results obtained with
sera and filter paper eluate for 15 individuals. All HBsAg
positive results were confirmed (Murex HBsAg Confir-
matory test, Version 3). The interpretation of the serolo-
gical assays was as stated by the manufacturers.
Statistical analysis
Epi-Info Version 2000 (CDC, USA & WHO Geneva,
Switzerland) software was used for analyzing data: pre-
valence, 95% confidence intervals and Chi-square test
for the comparison of variables and association of HBV
positivity and risk factors. Statistical significance was
assessed at p < 0.05.
Results
The surveyed population of adolescents and young
adults consisted of 455 (56.7%) males and 347 (43.3%)
females (sex ratio = 1.31). Age ranged from 14 to 48
years (mean 20.8, SD ± 4.1). They were from public
(336, 41.9%) and private (239, 29.8%) high schools and
the University of Bangui (226, 28.2%).
The preliminary tests of 15 samples from DBS have
shown a good correlation of results with the test per-
formed on sera but for one patient. However, confirma-
tory test showed that it was a false HBs positivity (table
1). Among the young adults, 339 were HBV positive
(Table 2), and of these 124 (15.5%) had an active infec-
tion. Ten (10, 1.3%) had “HBsAg only”. Prior infections
were detected in 215 individuals (26.8%) of whom only
8 (1.0%) had anti-HBs. None of the 801 individuals was
vaccinated against HBV.
There was no statistical difference between the preva-
lence of HBV infection markers according to sex, age
(Table 3) or place of residence. However, students from
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living in close proximity had the highest prevalence of
HBV infections while those from Districts 2 and 3 with
a higher living standard had the lowest.
Among the risk factors (Table 4), there was no asso-
ciation between HBV infection and socio-economic con-
ditions. However, the prevalence of HBV infection
markers was significantly higher: i) in orphans (OR 1.47,
95% CI 1.05-2.06), ii) in individuals attending public
high school in comparison to those from private high
school or the university (OR 2.8, 95% CI 1.95-4.03; OR
2.38, 95% CI 1.66-3.43), iii) when HBV familial antece-
dent are reported (OR 1.80, 95% CI 1.21-2.93) and
Table 1 Comparison of the sensitivity and specificity of
HBsAg and Anti-HBc Ab detection in DBS and sera
Positive Negative Confirmatory
test
n Sera DBS Sera DBS Sera DBS
HBsAg 15 9 10 6 5 9 9
Anti-HBc Ab 15 10 10 5 5 NA* NA
Anti-HBs Ab 5 1 1 4 4 NA NA
Sensitivity HBsAg 100%
Anti-HBc Ab 100%
Specificity HBsAg 83.3%
#
Anti-HBc Ab 100%
*NA: Not Applicable
#100% after confirmatory test.
Table 2 Prevalence of hepatitis B markers detected in
801 students in Bangui
Serological markers
present
Number (% of
total*)
95% CI
HBsAg 124 (15.5) 13.0 - 18.0
HBsAg only 10 (1.3) 0.5 - 2.0
HBsAg, Anti-
HBc Ab
114 (14.2) 11.8 - 16.6
Anti-HBc Ab only 207 (25.8) 23.1 - 29.3
HBsAg and/or Anti-
HBc Ab
331 (41.3) 37.9 - 44.7
Anti-HBs Ab/Anti-HBc
Ab
8 (1.0) 1.2 - 6.2
*801 individuals
Table 3 HBV positivity according to sex and age among
801 students in Bangui
Male Female
Age
(Years)
Total *HBV+
(%)
95% CI Total *HBV+
(%)
95% CI
14-19 149 41.6 33.6-49.6 195 43.1 36.1-50.1
20-25 234 43.2 36.8-49.6 125 48.0 39.2-56.8
≥ 26 71 32.4 21.2-43.6 27 33.3 14.7-51.9
Total 454 40.1 35.5-44.7 347 45.2 39.9-50.5
*HBV(+): one of the markers (HBsAg, anti-HBc Ab and anti-HBs Ab) at least is
positive
Table 4 Risk factors of HBV in 801 students in Bangui
(univariate analysis)
Variable n %HBV+ Odds Ratio 95% CI
Parents
One or two are dead 196 49.5 1.47 1.05-2.06
Both are alive 605 40 1
Education
Public High School 336 55.7 1
Private High School 239 31 2.80 1.95-4.03
University 226 34.5 2.38 1.66-3.43
HBV Familial antecedent
Yes 100 56 1.80 1.21-2.93
No 701 40.4 1
Marital Status
Single 701 42.4 0.99 0.63-1.64
Married 100 42 1
Tattooing
Yes 27 42.4 1.00 0.43-2.83
No 774 40.7 1
Dental Surgery
Yes 185 38.4 1.24 0.87-1.76
No 616 43.5 1
Surgery
Yes 76 32.9 0.16 0.11-0.22
No 725 43.3 1
Body piercing
Yes 564 40.6 1.27 0.92-1.74
No 237 46.4 1
Blood Transfusion
Yes 33 39.4 1.13 0.53-2.45
No 768 42.4 1
Alcohol Use
Yes 372 43.5 0.91 0.68-1.22
No 429 41.3 1
Injecting Drug Use
Yes 8 37.5 NA -
No 793 42.4
Use of Condoms
Yes 454 39.6 1
No 177 52.5 1.69 1.17-2.43
Sexual experience
Yes 631 43.7 1.76 0.53-1.09
No 170 37.1 1
Years since first intercourse
≤ 1 126 44.4 1
2 - 3 177 48 0.87 0.53-1.41
> 3 321 40.5 1.18 0.76-1.82
Number of sexual Partner
One (1) partner
(Male) 94 47.9 1.02 0.58-1.81
(Female) 126 48.4 1
Two (2) or more partner
(Male) 312 38.2 1,87 1.15-3.03
(Female) 99 53.3 1
*NA = Not Applicable because number (n) is very low
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1.69, 95% CI 1.17-2.43) and have 2 or more sexual part-
ner (OR1.87, 95% CI 1.15-3.03). Other variables that
m a yb ec o n s i d e r e da sh i g hr i s kf a c t o r ss u c ha sb o d y
piercing, tattooing, marital status, profession of parents,
alcohol use, years since first sexual intercourse, surgery,
dental surgery or blood transfusion were associated to a
moderate higher risk of HBV infection without any sta-
tistical significance. Finally, it has to be noted that three
of the eight people who had admitted the use of an
illicit drug were infected.
Discussion
In our study, serology was the method of choice as it
permits a direct evaluation of the prevalence of HBV
infections. The dried blood spot technique gives reliable
results with sensitivity and specificity almost identical to
serum testing. The collection of blood samples is made
easy using finger pricks [15-17]. It reduces the cost of
t h es u r v e ya n d ,a si ti sa l m o s tp a i n l e s s ,t h er i s ko fr e f u -
sal is minimized (and there was none in this study). The
high prevalence of HBV infection in young individuals
from Bangui, with global HBsAg prevalence of 15.5%
clearly confirms the complete absence of any program
to combat hepatitis B. This is evident when comparing
the rates in developed countries [18,19], or countries
who have implemented prophylaxis of this infection
[20-22]. The vaccination of infants in the first 11
months will have only a limited impact unless a follow
up is implemented and the prevention of mother to
infant transmission put in place.
The population of adolescents and young adults in our
study consist of all 8 districts of Bangui and from the
adjacent city of Bimbo. To determine the risk factors of
transmission of HBV in the chosen population, it would
be better to survey separately each social level of the
population, but, in the absence of any HBV education
program in the country it would be difficult to reach
the entire population. Public high schools in Bangui and
the University are attended by student whatever their
social status and the place they live in. However, private
schools accept solely students who can afford the fees
and are thus from middle and upper class. They repre-
sent at least 30% of the adolescent and young adult
population. Thus, our study population represents the
educated adolescents and young adults living in an
urban environment. This population is selected and thus
do not reflect the general population. A survey should
be conducted with the help of the health authorities to
evaluate the rate of HBV infection in the general
population.
The prevalence of HBsAg in our study was not corre-
lated with age. As indicated by the survey in children
[9] most chronic infections in Bangui are related to
mother to infant transmission or infection at a young
age. Acquired infection, mainly sexually, in later age,
resolves for it most part spontaneously. Thus the preva-
lence of anti-HBc increases regularly while the one of
HBsAg augments only moderately.
Only 3.7% of participants have detectable anti-HBs
antibodies in this study. This observation requires
further investigation to determine the reason why this
study shows such a very low detectable anti-HBs anti-
body level. This is not due to a loss of the sensitivity of
the DBS as it had been shown with the preliminary tests
as well as observations from other studies [14,17].
Although infection in neonates can explain an immuno-
tolerance phenomenon, the absence of anti-HBs in
young adults is puzzling and requires further investiga-
tion. This may be due to some characteristics of the
population. A variant of the HBs-antigen may be readily
detected while the corresponding antibodies are not. It
remains to be determined if this observation is related
to the E genotype [6,23].
In our study, there was no evident direct association
between socio-economic conditions and HBV infections.
However, although not significant, district with low
income correspond to higher proportion of infected
individuals. Thus it is likely that geographic origin and
income are two dependant variables. Nevertheless the
role of socio-economic status is reinforced by the higher
prevalence of infection in students from public high
schools in which they are accepted free of charge. This
is not the case in private schools, which only part of the
population can afford to attend, as already observed
[24]. The same conclusion can be made for the students
who attend the university.
In this study, HBV infection may also be mainly linked
to sexual transmission. In fact, risk factors, such as life-
time number of sexual partners > 2 and non use of con-
doms, were associated with HBV in the univariate
analysis. This is not surprising as sexual transmission is
an important route of HBV infection. The role of drug
use cannot be estimated as only eight students declared
use of injecting-drugs of whom three were infected with
HBV. Intrafamilial transmission may also play a role in
HBV infection of young people as living in a family in
which one member is infected is also a risk factor
[25,26]. Dental care is a moderate risk factor, likely
b e c a u s eo fl a c ko fh y g i e n e .C o n trarily, hospitalization
seems to have no role in HBV transmission.
Conclusion
This survey, the first performed in a population of
young healthy educated adults in Bangui, indicates a
high prevalence of HBV infection. The increase in anti-
HBc prevalence in teens as previously described [9] and
the one we observed are in favor of sexually acquired
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role as the absence of education and the low income
favor HBV infection. Altogether, the high prevalence of
infected young adults reflects the absence of health pol-
icy for fighting against this disease. This is alarming and
taking into account the high risk of HBV transmission
in the country by health authorities may reduce drama-
tically the burden of this disease. Information of the
population, focusing mainly on adolescents, vaccination
not only of infants but also of the entire population and
a prophylaxis of mother to infant transmission are to be
implemented.
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